MRK
Stock Details
MRK is Merck & Co., Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 109.27$. Average daily volumn in 3 months 9.16M. Market cap 267.18B
Stock symbol : MRK. Exchange : NYSE. Currency : USD Lastest price : 105.38$. Total volume : 7.78M. Market state CLOSED Click reload if you want to check the lastest price on market!!!
Merck & Co., Inc. (MRK)
Last Price
105.38$Change
-1.49Volume
7.78M
| Previous Close | 106.87 |
| Open | 106.21 |
| Day Range | 105.11-106.68 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 1.1k |
| Volume | 7.78M |
| Average Volume | 9.16M |
| Market Cap | 267.18B |
| Beta | 0.39 |
| 52 Week Range | 72.88-115.49 |
| Trailing P/E | 17.48 |
| Foward P/E | 14.24 |
| Dividend (Yield %) | 2.73% |
| Ex-Dividend Date | 2023-03-14 |
Financial Details
Organization
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuti... cals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Market Cap:
267.18BRevenue:
48.7BTotal Assets:
105.69BTotal Cash:
8.1B
News about "Merck & Co., Inc."
Merck (NYSE:MRK) Has Announced That It Will Be Increasing Its Dividend To $0.73
Source from : YAHOO!News - 22 hours ago
Merck & Co., Inc. ( NYSE:MRK ) will increase its dividend from last year's comparable payment on the 10th of April ...See details»
Merck & Co. Inc. stock outperforms market on strong trading day
Source from : MarketWatch - 3 days ago
Shares of Merck & Co. Inc. inched 0.06% higher to $108.59 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with ...See details»
Merck & Co. Inc. stock underperforms Tuesday when compared to competitors
Source from : MarketWatch - 4 days ago
Shares of Merck & Co. Inc. slipped 1.24% to $108.52 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the ...See details»
Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It
Source from : Zacks.com on MSN - 11 days ago
Merck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over the ...See details»
Merck's Keytruda extends survival in bile duct cancer patients
Source from : Reuters - 3 days ago
Merck & Co Inc said on Wednesday its blockbuster cancer drug Keytruda in combination with a chemotherapy showed significant improvement in overall survival in patients with an advanced type of bile ...See details»
Merck & Co., Inc.
Source from : CSR Wire - 13 days ago
Merck was named one of America’s Most JUST Companies, making this the sixth consecutive year that Merck has been recognized for its commitment to serving its workers, customers, communities, the ...See details»
Do You Think Merck & Co. (MRK) is an Attractive Investment?
Source from : Yahoo Finance - 3 days ago
Smead Capital Management highlighted stocks like Merck & Co., Inc. (NYSE:MRK) in the Q4 2022 investor letter. Headquartered in Kenilworth, New Jersey, Merck & Co., Inc. (NYSE:MRK) is a healthcare ...See details»
Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock
Source from : Nasdaq - 1 month ago
Shares of this pharmaceutical company have returned +4.1% over the past month versus the Zacks S&P 500 composite's -4.4% change. The Zacks Large Cap Pharmaceuticals industry, to which Merck ...See details»
Merck & Co Stock (NYSE:NYSE:MRK), Guidance and Forecast
Source from : Benzinga.com - 3 days ago
so investors have a sense of how much money a company will make in a future period. There have been no specific sales or earnings guidance reported for Merck & Co in recent months. Browse guidance ...See details»
Is a Correction Looming Ahead for Merck & Co. Inc. (MRK)
Source from : newsheater - 2 years ago
Merck & Co. Inc. (NYSE:MRK) went down by -1.60% from its latest closing price compared to the recent 1-year high of $115.49. The company’s stock price has collected 0.06% of gains in the last five ...See details»
Merck & Co Stock (NYSE:NYSE:MRK), Earnings Estimates, EPS, and Revenue
Source from : Benzinga.com - 3 days ago
Merck & Co reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost ...See details»
Where Merck & Co Stands With Analysts
Source from : Business Insider - 5 days ago
Merck & Co (NYSE:MRK ... Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their ...See details»
What Direction Does Merck & Co. Inc. (NYSE: MRK) Analysts Think The Company Will Take?
Source from : stocksregister - 5 month ago
The trading price of Merck & Co. Inc. (NYSE:MRK) floating lower at last check on Wednesday, January 18, closing at $109.32, -1.02% lower than its previous close. Traders who pay close attention to ...See details»
Merck & Co., Inc.: Merck Named One of America's Most JUST Companies by JUST Capital and CNBC, Industry Leader in Pharmaceuticals and Biotech
Source from : Finanznachrichten - 15 days ago
Merck ranked No. 26 overall and ranked No. 1 in the pharmaceuticals and biotech industry for the third straight year, notably also ranking as the top company for communities and customers in the ...See details»